Irbesartan Zentiva 150 mg film-coated tablets
*Company:
Zentiva Pharma UK LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 31 January 2025
File name
SPC 150 MG IE clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 31 January 2025
File name
For EMC m1-3-2-pil-mock-up-150 mg.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 24 October 2024
File name
1.3.1 SPC 150mg FCT clean.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 24 October 2024
File name
FOR EMC NI 72524 PIL_IRBESARTAN ZTV 150MG_GB.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation holder
Updated on 21 February 2023
File name
1.3.1 SPC150mg FCT-clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 21 February 2023
File name
For medicines ie 66439 PIL_IRBESARTAN ZTV 150MG_GB-final.pdf
Reasons for updating
- New PIL for new product
Zentiva Pharma UK Limited
Address:
First Floor, Andrews House, College Road, Guildford, GU1 4QB, UKMedInfo@zentiva.comTelephone:
+353 818 882 243Medical Information Direct Line:
+353 818 882 243 ,